- Home
- VIR vs AMAL Comparison
VIR vs AMAL Comparison
Compare VIR & AMAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIR
- AMAL
- Stock Information
- Founded
- VIR 2016
- AMAL 1923
- Country
- VIR United States
- AMAL United States
- Employees
- VIR N/A
- AMAL N/A
- Industry
- VIR Biotechnology: Pharmaceutical Preparations
- AMAL Commercial Banks
- Sector
- VIR Health Care
- AMAL Finance
- Exchange
- VIR Nasdaq
- AMAL Nasdaq
- Market Cap
- VIR 1.0B
- AMAL 1.1B
- IPO Year
- VIR 2019
- AMAL 2018
- Fundamental
- Price
- VIR $7.12
- AMAL $36.51
- Analyst Decision
- VIR Buy
- AMAL Buy
- Analyst Count
- VIR 5
- AMAL 3
- Target Price
- VIR $36.40
- AMAL $32.17
- AVG Volume (30 Days)
- VIR 1.6M
- AMAL 236.7K
- Earning Date
- VIR 10-31-2024
- AMAL 10-24-2024
- Dividend Yield
- VIR N/A
- AMAL 1.31%
- EPS Growth
- VIR N/A
- AMAL 16.43
- EPS
- VIR N/A
- AMAL 3.39
- Revenue
- VIR $78,618,000.00
- AMAL $303,032,000.00
- Revenue This Year
- VIR N/A
- AMAL N/A
- Revenue Next Year
- VIR N/A
- AMAL $4.24
- P/E Ratio
- VIR N/A
- AMAL $10.77
- Revenue Growth
- VIR N/A
- AMAL 12.76
- 52 Week Low
- VIR $6.56
- AMAL $20.39
- 52 Week High
- VIR $13.09
- AMAL $38.19
- Technical
- Relative Strength Index (RSI)
- VIR 38.72
- AMAL 60.14
- Support Level
- VIR $6.56
- AMAL $33.58
- Resistance Level
- VIR $10.13
- AMAL $37.53
- Average True Range (ATR)
- VIR 0.56
- AMAL 1.16
- MACD
- VIR -0.29
- AMAL -0.06
- Stochastic Oscillator
- VIR 14.43
- AMAL 68.12
About VIR Vir Biotechnology Inc.
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.
About AMAL Amalgamated Financial Corp. (DE)
Amalgamated Financial Corp is a bank holding company. It is a full-service commercial bank and a chartered trust company. It provides commercial banking and trust services nationally and offers a range of products and services to commercial and retail customers. It offers a complete suite of commercial and retail banking, investment management, and trust and custody services.